InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NWG | Ann: mFund - Monthly Redemption Report - NWG01 | 04/03/19 | 0 | 63 | |||
|
|||||||
NWG | Ann: mFund - Monthly Redemption Report - NWG01 | 05/02/19 | 0 | 66 | |||
|
|||||||
NWG | Ann: mFund - Monthly Redemption Report - NWG01 | 04/01/19 | 0 | 115 | |||
|
|||||||
NWG | Ann: mFund - Distribution - JHI02 | 04/01/19 | 0 | 139 | |||
|
|||||||
NWG | Ann: mFund - Monthly Redemption Report - JHI02 | 04/01/19 | 0 | 112 | |||
|
|||||||
NWG | Ann: mFund - Distribution - JHI03 | 04/01/19 | 0 | 115 | |||
|
|||||||
NWG | Ann: mFund - Monthly Redemption Report - JHI03 | 04/01/19 | 0 | 120 | |||
|
|||||||
NWG | Ann: mFund - Monthly Redemption Report - JHI02 | 05/12/18 | 0 | 90 | |||
|
See All Discussions